May 13, 2026 09:00AM
Dec 1, 2023 04:05PM
Nov 22, 2023 08:30AM
Nov 7, 2023 04:00PM
Nov 7, 2023 04:00PM
Oct 27, 2023 08:30AM
Oct 12, 2023 09:00AM New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease
Oct 4, 2023 04:05PM
Oct 4, 2023 04:05PM
Sep 28, 2023 04:05PM
Sep 28, 2023 08:15AM
Sep 27, 2023 09:00AM
Sep 27, 2023 09:00AM
Sep 21, 2023 04:05PM Veracyte Announces Novel Afirma-Based Findings that Advance Molecular Understanding of Thyroid Cancer to Be Presented at the 2023 ATA Annual Meeting
Aug 22, 2023 08:15AM
Aug 1, 2023 08:15AM
Aug 1, 2023 08:15AM
Jun 20, 2023 08:31AM
Jun 12, 2023 08:31AM
May 25, 2023 05:13PM
May 24, 2023 09:00AM New Data Presented at ATS 2023 Reinforce Clinical Utility of Veracyte’s Genomic Tests in Interstitial Lung Disease and Lung Cancer
May 4, 2023 09:45AM
May 3, 2023 05:44PM
May 2, 2023 04:06PM
May 2, 2023 04:05PM
May 1, 2023 05:35PM
Apr 29, 2023 04:31PM
Apr 17, 2023 08:30AM New Data Reinforce Ability of Veracyte’s Decipher Prostate Genomic Classifier To Help Identify Prostate Cancer Patients Who Would Benefit from Treatment Intensification
Apr 12, 2023 08:30AM
Feb 15, 2023 08:38AM
Feb 15, 2023 08:36AM
Feb 13, 2023 05:23PM
Feb 1, 2023 04:05PM
Feb 1, 2023 08:33AM
Feb 1, 2023 08:32AM Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules
Dec 15, 2022 04:05PM
Oct 25, 2022 08:30AM
Oct 24, 2022 08:30AM
Oct 18, 2022 04:05PM
Sep 22, 2022 08:56AM
Sep 22, 2022 08:55AM
Sep 13, 2022 08:30AM Veracyte Names John Leite, Ph.D., as General Manager of Pulmonology & Market Access
Sep 12, 2022 05:43AM
Sep 11, 2022 02:30AM
Sep 7, 2022 04:55PM
Sep 7, 2022 04:54PM
Aug 31, 2022 07:00AM
Jul 20, 2022 04:16PM
Jul 20, 2022 04:15PM Veracyte Announces New Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer Classifier Published in Thyroid
Jul 13, 2022 04:16PM

323,571 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All